| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.33▼ | 2.30▲ | 2.30▲ | 2.53▼ | 2.59▼ |
| MA10 | 2.31▲ | 2.28▲ | 2.39▼ | 2.66▼ | 2.70▼ |
| MA20 | 2.28▲ | 2.43▼ | 2.52▼ | 2.58▼ | 3.14▼ |
| MA50 | 2.41▼ | 2.55▼ | 2.67▼ | 2.72▼ | 5.49▼ |
| MA100 | 2.49▼ | 2.82▼ | 2.94▼ | 3.21▼ | 12.64▼ |
| MA200 | 2.83▼ | 3.17▼ | 3.36▼ | 4.52▼ | 35.93▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.018▲ | -0.004▼ | -0.016▼ | -0.016▼ | 0.161▲ |
| RSI | 49.244▼ | 42.392▼ | 40.478▼ | 35.868▼ | 35.738▼ |
| STOCH | 80.548▲ | 37.567 | 23.856 | 41.975 | 26.611 |
| WILL %R | -32.258 | -66.667 | -66.667 | -71.084 | -83.893▼ |
| CCI | 43.111 | -24.250 | -61.210 | -117.699▼ | -151.196▼ |
|
Monday, April 28, 2025 05:31 AM
Purple Biotech Ltd. (NASDAQ/TASE: PPBT) is a clinical-stage company developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance. The Company's oncology ...
|
|
Thursday, April 24, 2025 05:00 PM
The panel titled “New Radiotherapy and Targeted Therapy Approaches REHOVOT, Israel, March 28, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT ...
|
|
Tuesday, April 22, 2025 01:57 PM
An update from Purple Biotech ( ($PPBT) ) is now available. On April 22, 2025, Purple Biotech Ltd. held its Annual General Meeting of ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/05/25 | 2.3724 | 2.45 | 2.30 | 2.35 | 92,788 |
| 30/04/25 | 2.54 | 2.7081 | 2.11 | 2.40 | 4,454,858 |
| 29/04/25 | 2.53 | 2.53 | 2.53 | 2.53 | 14,072 |
| 28/04/25 | 2.48 | 2.69 | 2.3701 | 2.65 | 578,170 |
| 25/04/25 | 2.91 | 2.9291 | 2.70 | 2.70 | 3,795 |
| 24/04/25 | 2.80 | 2.94 | 2.7001 | 2.73 | 7,616 |
| 23/04/25 | 2.89 | 2.89 | 2.665 | 2.6724 | 8,968 |
| 22/04/25 | 2.76 | 2.89 | 2.76 | 2.88 | 3,426 |
| 21/04/25 | 2.83 | 2.86 | 2.76 | 2.84 | 9,046 |
| 17/04/25 | 2.54 | 2.84 | 2.54 | 2.84 | 14,482 |
|
|
||||
|
|
||||
|
|